European firms aren’t alone in their Brexit pain – Pfizer, the US-based drug behemoth, says its costs for dealing with the upcoming split will reach $100m (€86.4m). The UK’s looming rupture with the EU threatens to slow goods at borders and force firms to duplicate regulatory efforts. Pfizer said its costs stem from transferring product […]